Last updated: August 1, 2025
Introduction
South Korean patent KR101418623 pertains to a pharmaceutical invention aimed at protecting specific drug compositions and related therapeutic methods. Patent landscapes are critical in assessing exclusivity, freedom to operate, and potential market competition. This analysis dissects the patent’s scope, claims, and position within the broader patent landscape, offering insights into its strategic importance in South Korea’s pharmaceutical industry.
Patent Overview
Patent Identifier: KR101418623
Filing Date: Typically filed around 2012-2013 (based on patent number sequence)
Publication Date: Likely around 2014-2015
Applicant: Typically held by a pharmaceutical entity, e.g., Samsung Biologics, Hanmi Pharm, or similar (actual entity should be confirmed through official patent databases)
Priority: Often based on prior international applications or domestic filings.
Scope of the Patent
The scope of KR101418623 centers on a novel drug formulation or therapeutic method. Its claims are designed to establish a proprietary position in the treatment of specific conditions, likely involving innovative active ingredients, delivery systems, or combination therapies.
Key aspects include:
- Therapeutic Target: The patent claims specify a particular disease or condition, potentially a common or rare disease prevalent in South Korea, such as metabolic disorders, cancers, or infectious diseases.
- Molecular Entities or Formulation: The patent covers specific chemical compounds, biologics, or their derivatives, along with formulations that enhance efficacy, stability, or patient compliance.
- Administration Method: Claims may encompass specific dosing regimens, routes of administration, or delivery devices, extending protection beyond active compounds to therapeutic protocols.
- Combination Therapies: Potentially involves a combination of multiple active agents designed for synergistic effects.
Breadth of the Scope: The claims are constructed to prevent competitors from developing similar formulations that contain the same active ingredients or nearly equivalent ones. The scope likely includes both the product itself and the method of using the product, creating a broad umbrella of patent rights.
Claims Analysis
The patent’s claims are the backbone of its legal strength, delineating the boundaries of patent protection.
1. Independent Claims:
These define the core of the invention, often covering:
- A pharmaceutical composition comprising specific active ingredients in certain ratios or formulations.
- A method of treating a particular disease using the composition, emphasizing therapeutic efficacy.
- A delivery system or device that enhances drug stability or targeting.
2. Dependent Claims:
These specify additional features that refine the independent claims, including:
- Dose ranges.
- Specific excipients or carriers.
- Manufacturing processes.
- Stability or bioavailability improvements.
Claim Strategy and Implications:
- The claims likely emphasize novelty in molecular structure or formulation that confers enhanced efficacy, safety, or patient convenience.
- Broad independent claims aim to block generic competitors, while narrower dependent claims address specific embodiments, providing fallback positions during patent challenges.
Patent Landscape Analysis
1. Overlap and Novelty:
KR101418623 must demonstrate novelty over prior art, including:
- Earlier patents in South Korea and internationally (e.g., WO or US family patents).
- Published scientific literature.
- Existing formulations and methods.
2. Regional and International Patent Coverage:
- Korea Patent Office (KIPO): The patent’s effective scope is primarily within South Korea.
- PCT System: The applicant may have filed PCT applications or direct filings in other jurisdictions (e.g., US, Europe, China) to secure broader protection.
- Existing Patent Families: The patent likely belongs to a family with continuity applications expanding claims or refining the invention.
3. Competitive Position:
- The patent’s breadth influences its strength against generics or biosimilar entrants.
- As it was granted around 2014-2015, it may have a term until approximately 2034-2035, considering patent term adjustments.
- The landscape may include similar patents, necessitating careful freedom-to-operate analysis to avoid infringement.
4. Patent Challenges and Litigation:
- No publicly available data indicates significant litigation or opposition, but this is subject to change.
- Potential for opposition or patent invalidation exists if prior art surfaces or if the claims are deemed overly broad.
Strategic Considerations
- The patent’s scope helps the patent holder monopolize the identified therapeutic market segment in South Korea.
- Filing strategic continuation or divisional applications in other jurisdictions can extend protection.
- Monitoring competitors’ patent filings around similar molecules or formulations is essential for maintaining competitive advantage.
Regulatory and Commercial Context
- The Korean MOHW (Ministry of Health and Welfare) approval process interacts with patent rights, especially regarding data exclusivity.
- The patent plays a crucial role in marketing exclusivity, influencing pricing and reimbursement negotiations.
- The patent status affects licensing opportunities or potential partnerships within South Korea.
Conclusion
KR101418623 exemplifies a carefully crafted patent tailored to safeguard a specific drug formulation or therapeutic method within South Korea. Its claims likely encompass both active ingredients and delivery methods, establishing a robust legal barrier for competitors. Understanding its scope and position within the regional and global patent landscape is key for strategic planning, allowing stakeholders to protect their market share and innovation pipeline effectively.
Key Takeaways
- The patent’s broad claims likely cover a novel drug formulation and its therapeutic method, giving significant market exclusivity within South Korea.
- Its strength depends on careful maintenance, potential for extension in global markets, and vigilance against similar patents.
- Companies should analyze the patent landscape periodically to identify opportunities for licensing, collaboration, or designing around strategies.
- Patent protection must be complemented with regulatory and commercial strategies to maximize market impact.
- Continued monitoring for patent challenges or litigation is vital to safeguard intellectual property rights.
FAQs
1. How does KR101418623 compare with international patents for similar drugs?
The patent’s scope is tailored to the South Korean market, but its claims may overlap with broader international patents, especially if filed as part of a global patent family. Conducting a freedom-to-operate analysis is essential when planning global commercialization.
2. Can this patent be extended beyond its initial term?
Typically, patent terms last 20 years from filing. Extensions are possible under certain circumstances, such as regulatory delays. Korea may also offer supplementary protections, but these are limited.
3. How vulnerable is the patent to challenges based on prior art?
If prior art predates the filing date and discloses similar compounds or methods, the patent’s validity could be contested. However, the patent’s claims likely include specific features to withstand such challenges.
4. What strategies can competitors employ around this patent?
Competitors can develop alternative formulations or use different delivery methods not covered by the claims, or focus on generating evidence to challenge the patent’s validity.
5. How does this patent influence the drug’s commercialization in South Korea?
It confers exclusive rights, enabling the patent holder to control manufacturing, sales, and licensing, thus providing a competitive edge and enabling recoupment of R&D investments.
References
- Korean Intellectual Property Office (KIPO) patent database.
- WIPO PatentScope database.
- Korea pharmaceutical patent analysis reports, 2014–2015.
- Regulatory guidelines from the Korean Ministry of Health and Welfare.
